pminews.it
MILANO (AIMnews.it) - The UBI Banca analysts confirm for Bomi Italia, active in the biomedical logistics sector, the BUY rating and raise the target price to 4.62 Eu (from 4.31 Eu), with a potential upside of more than 45%. According to analysts, the 2017 results exceeded expectations, in terms of organic growth and improvement in margins, due to a better geographical mix and a significant business growth in Brazil, Latam, Turkey and China. Net profit for 2017 was € 2.7 million (+ 86% vs. 2016). The management confirmed its stand-alone plan in January, which envisages a further improvement in profitability thanks to the growing contribution of emerging countries.
pminews.it
02/04/2026
pminews.it
01/04/2026
pminews.it
01/04/2026
pminews.it
01/04/2026